Actinium Pharmaceuticals
ATNM
#9636
Rank
A$62.43 M
Marketcap
$2.00
Share price
0.79%
Change (1 day)
-81.58%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -A$63.57 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -A$81.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 -A$65.86 Million-18.87%
2023 -A$81.18 Million52.24%
2022 -A$53.33 Million36.61%
2021 -A$39.04 Million11.48%
2020 -A$35.02 Million1.46%
2019 -A$34.51 Million-7.37%
2018 -A$37.26 Million-11.46%
2017 -A$42.08 Million10.67%
2016 -A$38.02 Million15.7%
2015 -A$32.87 Million-14.86%
2014 -A$38.6 Million129.19%
2013 -A$16.85 Million-8.55%
2012 -A$18.42 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.05 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$58.15 Million-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.84 B-1,386.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$44.97 Million-31.73%๐Ÿ‡บ๐Ÿ‡ธ USA